Difference of early response to renal anemia in erythropoiesis-stimulating agents.

Difference of early response to renal anemia in erythropoiesis-stimulating agents. - Difference of early response to renal anemia in erythropoiesis-stimulating agents

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017326

Enrollment

400

Registered

2015-04-29

Start date

2005-04-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease with renal anemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Chronic kidney disease patients with renal anemia who were required to treat by erythropoiesis-stimulating agents.

Exclusion criteria

Exclusion criteria: Patients complicated with potential diseases causing anemia such as hemorrhagic disease, hematological disease, or carcinoma.

Design outcomes

Primary

Measure	Time frame
After 12 wk administration of erythropoiesis-stimulating agent (ESA), the degree of increase in hemoglobin adjusted by body weight and amount of ESA was compared in three kinds of ESAs.	—

Secondary

Measure	Time frame
After 12 wk administration of erythropoiesis-stimulating agent (ESA), factors which affected the responsiveness to renal anemia was determined in each ESA.	—

Countries

Japan

Contacts

Public ContactMichio Kuwahara

Shuuwa General Hospital Department of Nephrology

kuwaharam@shuuwa-gh.or.jp048-737-2121

Outcome results